Cover Image
市場調查報告書

卡波西氏肉瘤治療市場 - 全球產業分析,規模,構成比,成長率,趨勢及預測

Kaposi Sarcoma Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

出版商 Transparency Market Research 商品編碼 370773
出版日期 內容資訊 英文 131 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
卡波西氏肉瘤治療市場 - 全球產業分析,規模,構成比,成長率,趨勢及預測 Kaposi Sarcoma Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
出版日期: 2016年08月11日 內容資訊: 英文 131 Pages
簡介

卡波西氏肉瘤有是在結締組織和血管、線維組織、肌肉發病的軟性組織肉瘤,特徵是泛藍紅色的皮膚結節在腿部擴大的惡性、多中心性、腫瘤性的血管增生疾病。美國疾病對策預防中心 (Centers for Disease Control and Prevention) ,將此分類為後天性免疫機能喪失症候群 (AIDS)的一種。

本報告以全球卡波西氏肉瘤治療相關市場為焦點,提供今後各療法、流通管道及地區的交易規模的變化預測,其法規環境,開發平台,推動、阻礙因素及機會,產業結構等分析資訊和主要加入企業簡介彙整。

第1章 序

  • 市場定義和範圍
  • 市場區隔
  • 調查的主要目的
  • 調查焦點

第2章 前提條件與調查方法

第3章 摘要整理 - 卡波西氏肉瘤的全球市場

第4章 市場概要

  • 簡介
  • 重要市場指標
  • 法規情形
  • 市場動態
    • 推動要素
    • 阻礙因素
    • 機會
  • 價值鏈分析

第5章 卡波西氏肉瘤治療的全球市場 - 各療法

  • 重要發現
  • 卡波西氏肉瘤治療的全球市場 - 各治療形式
  • 化療
    • Liposomal Anthracyclines
    • 生物鹼治療
  • 免疫療法
  • 高活性抗逆轉錄病毒療法 (HAART)
  • 卡波西氏肉瘤治療的全球市場向心力 - 各療法

第6章 卡波西氏肉瘤治療的全球市場 - 各流通管道

  • 卡波西氏肉瘤治療的全球市場 - 各流通管道
    • 醫院
    • 癌症研究機關
    • 綜合診療所
    • 門診外科中心
  • 卡波西氏肉瘤治療的全球市場向心力 - 各流通管道

第7章 卡波西氏肉瘤治療的全球市場 - 各地區

  • 卡波西氏肉瘤治療的全球市場 - 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中南美
    • 中東、非洲
  • 卡波西氏肉瘤治療的全球市場向心力 - 各地區

第8章 卡波西氏肉瘤治療的全球市場 - 開發平台分析

  • 概要
  • 初期藥物候補一覽

第9章 北美的卡波西氏肉瘤治療市場

  • 北美的卡波西氏肉瘤治療市場 - 各治療形式
    • 化療
    • 免疫療法
    • 高活性抗逆轉錄病毒療法
  • 北美的卡波西氏肉瘤治療市場 - 各流通管道
    • 醫院
    • 癌症研究機關
    • 綜合診療所
    • 門診外科中心
  • 北美的卡波西氏肉瘤治療市場 - 各國
    • 美國
    • 加拿大
  • 市場向心力 - 各治療形式
  • 市場向心力 - 各國

第10章 歐洲的卡波西氏肉瘤治療市場

  • 歐洲的卡波西氏肉瘤治療市場 - 各治療形式
    • 化療
    • 免疫療法
    • 高活性抗逆轉錄病毒療法
  • 歐洲的卡波西氏肉瘤治療市場 - 各流通管道
    • 醫院
    • 癌症研究機關
    • 綜合診療所
    • 門診外科中心
  • 歐洲的卡波西氏肉瘤治療市場 - 各國
    • 英國
    • 德國
    • 其他歐洲各國
  • 市場向心力 - 各治療形式
  • 市場向心力 - 各國

第11章 亞太地區的卡波西氏肉瘤治療市場

  • 亞太地區的卡波西氏肉瘤治療市場 - 各治療形式
    • 化療
    • 免疫療法
    • 高活性抗逆轉錄病毒療法
  • 亞太地區的卡波西氏肉瘤治療市場 - 各流通管道
    • 醫院
    • 癌症研究機關
    • 綜合診療所
    • 門診外科中心
  • 亞太地區的卡波西氏肉瘤治療市場 - 各國
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他亞太地區各國
  • 市場向心力 - 各治療形式
  • 市場向心力 - 各國

第12章 中南美的卡波西氏肉瘤治療市場

  • 中南美的卡波西氏肉瘤治療市場 - 各治療形式
    • 化療
    • 免疫療法
    • 高活性抗逆轉錄病毒療法
  • 中南美的卡波西氏肉瘤治療市場 - 各流通管道
    • 醫院
    • 癌症研究機關
    • 綜合診療所
    • 門診外科中心
  • 中南美的卡波西氏肉瘤治療市場 - 各國
    • 英國
    • 德國
    • 其他中南美各國
  • 市場向心力 - 各治療形式
  • 市場向心力 - 各國

第13章 中東、非洲的卡波西氏肉瘤治療市場

  • 中東、非洲的卡波西氏肉瘤治療市場 - 各治療形式
    • 化療
    • 免疫療法
    • 高活性抗逆轉錄病毒療法
  • 中東、非洲的卡波西氏肉瘤治療市場 - 各流通管道
    • 醫院
    • 癌症研究機關
    • 綜合診療所
    • 門診外科中心
  • 中東、非洲的卡波西氏肉瘤治療市場 - 各國
    • 英國
    • 德國
    • 其他中東、非洲各國
  • 市場向心力 - 各治療形式
  • 市場向心力 - 各國

第14章 卡波西氏肉瘤治療的全球市場 - 各類服務

  • 放射治療
  • 外科手術

第15章 競爭環境

  • 各企業成長、佔有率矩陣
  • 市場佔有率分析
  • 企業簡介
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Pfizer, Inc.

第16章 建議

目錄

Title: Kaposi Sarcoma Market (Treatment - Chemotherapy (Liposomal Anthracyclines, Alkaloids), Immunotherapy, HAART); Distribution Channel - Hospitals, Cancer Research Institutes, Multispecialty Clinics,Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.

Kaposi sarcoma is a soft tissue sarcoma that develops in connective tissues, blood vessels, fibrous tissues, and muscles. It is a malignant, multi-centric, neoplastic vascular proliferation, characterized by the development of bluish-red cutaneous nodules on the feet. According to the U.S. Center for Disease Control and Prevention (CDC), Kaposi sarcoma is considered an acquired immune deficiency syndrome (AIDS) defining disease. This report analyzes the current and future prospects of the Kaposi sarcoma market based on type of treatment, distribution channel, and geography.

The report is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of major Kaposi sarcoma therapies in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, and various international and national databases. The report provides estimated market size in terms of US$ Mn for each treatment method, distribution channel, and geography for the period 2014 to 2024, considering the macro and micro environmental factors. The revenue generated from each treatment method was calculated by considering number of patients, average cost of the drugs, trends in the industry, distribution channel trends, and adoption rate of therapy across all the geographies. The revenues generated from services, including surgery and radiation therapy were calculated based on the costs and average number of procedures.

The market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on type of treatment, distribution channel, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that influence the Kaposi sarcoma market in the current and future scenario. The report provides the list of drugs in various stages of clinical trials, which are expected to shape the future course of the market, through pipeline analysis. The report also provides value chain analysis of the market that describes the sequence of activities from drug manufacturing to the final destination, which is the end user.

Market share analysis is provided to highlight percentage share of the major players operating in the market. All these factors will help market players to decide business strategies and plans to strengthen their position in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Market forecast for major countries in these regions have also been provided for the forecast period.

In addition, this report includes a list of recommendations to aid new entrants and established players in taking strategic initiatives to strengthen their presence in the market. The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the Kaposi sarcoma market report are Bristol - Myers Squibb, Eli Lilly and Co., Hoffman-La Roche, Inc., GlaxoSmithKline plc, Johnson & Johnson, Pfizer, Inc., and Schering Plough Corporation (Merck & Co., Inc.)

The global Kaposi Sarcoma market has been segmented as follows:

Kaposi Sarcoma Market, By Type of Treatment

  • Chemotherapy
    • Liposomal Anthracyclines
    • Alkaloids
  • Immunotherapy
  • HAART

Kaposi Sarcoma Market, By Distribution Channel

  • Hospitals
  • Cancer Research Institutes
  • Multispecialty Clinics
  • Ambulatory Surgical Centers

Kaposi Sarcoma Market, By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • U.A.E.
    • South Africa
    • Rest of Middle East and Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Kaposi sarcoma market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Key market indicators
  • 4.3. Regulatory scenario
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunities
  • 4.5. Value Chain Analysis

5. Global Kaposi Sarcoma Market, by Treatment

  • 5.1. Key Findings
  • 5.2. Global Kaposi Sarcoma Market, by Type of Treatment, (US$ Mn), 2014-2024
    • 5.2.1. Chemotherapy
      • 5.2.1.1. Liposomal Anthracyclines
      • 5.2.1.2. Alkaloids
    • 5.2.2. Immunotherapy
    • 5.2.3. HAART
  • 5.3. Global Kaposi Sarcoma Market Attractiveness, by Treatment, 2015

6. Global Kaposi Sarcoma Market, by Distribution Channel

  • 6.1. Global Kaposi Sarcoma Market, by Distribution Channel, (US$ Mn), 2014-2024
    • 6.1.1. Hospitals
    • 6.1.2. Cancer Research Institutes
    • 6.1.3. Multispecialty Clinics
    • 6.1.4. Ambulatory Surgical Centers
  • 6.2. Global Kaposi Sarcoma Market Attractiveness, by Distribution Channel, 2015

7. Global Kaposi Sarcoma Market, by Region

  • 7.1. Global Kaposi Sarcoma Market, by Region, (US$ Mn), 2014-2024
    • 7.1.1. North America
    • 7.1.2. Europe
    • 7.1.3. Asia Pacific
    • 7.1.4. Latin America
    • 7.1.5. Middle East and Africa
  • 7.2. Global Kaposi Sarcoma Market Attractiveness, by Region, 2015

8. Global Kaposi Sarcoma Market, Pipeline Analysis

  • 8.1. Overview
  • 8.2. List of Early Stage Drug Candidates

9. North America Kaposi Sarcoma Market

  • 9.1. North America Kaposi Sarcoma Market, by Type of Treatment, (US$), 2014-2024
    • 9.1.1. Chemotherapy
    • 9.1.2. Immunotherapy
    • 9.1.3. HAART
  • 9.2. North America Kaposi Sarcoma Market, by Distribution Channel, (US$), 2014-2024
    • 9.2.1. Hospitals
    • 9.2.2. Cancer Research Institutes
    • 9.2.3. Multispecialty Clinics
    • 9.2.4. Ambulatory Surgical Centers
  • 9.3. North America Kaposi Sarcoma Market, by Country, (US$), 2014-2024
    • 9.3.1. U.S.
    • 9.3.2. Canada
  • 9.4. Market Attractiveness, by Type of Treatment, 2015
  • 9.5. Market Attractiveness, by Country, 2015

10. Europe Kaposi Sarcoma Market

  • 10.1. Europe Kaposi Sarcoma Market, by Type of Treatment, (US$), 2014-2024
    • 10.1.1. Chemotherapy
    • 10.1.2. Immunotherapy
    • 10.1.3. HAART
  • 10.2. Europe Kaposi Sarcoma Market, by Distribution Channel, (US$), 2014-2024
    • 10.2.1. Hospitals
    • 10.2.2. Cancer Research Institutes
    • 10.2.3. Multispecialty Clinics
    • 10.2.4. Ambulatory Surgical Centers
  • 10.3. EuropeKaposi Sarcoma Market, by Country, (US$), 2014-2024
    • 10.3.1. U.K.
    • 10.3.2. Germany
    • 10.3.3. Rest of Europe
  • 10.4. Market Attractiveness, by Type of Treatment, 2015
  • 10.5. Market Attractiveness, by Country, 2015

11. Asia Pacific Kaposi Sarcoma Market

  • 11.1. Asia Pacific Kaposi Sarcoma Market, by Type of Treatment, (US$), 2014-2024
    • 11.1.1. Chemotherapy
    • 11.1.2. Immunotherapy
    • 11.1.3. HAART
  • 11.2. Asia Pacific Kaposi Sarcoma Market, by Distribution Channel, (US$), 2014-2024
    • 11.2.1. Hospitals
    • 11.2.2. Cancer Research Institutes
    • 11.2.3. Multispecialty Clinics
    • 11.2.4. Ambulatory Surgical Centers
  • 11.3. Asia Pacific Kaposi Sarcoma Market, by Country, (US$), 2014-2024
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. Rest of Asia Pacific
  • 11.4. Market Attractiveness, by Type of Treatment, 2015
  • 11.5. Market Attractiveness, by Country, 2015

12. Latin America Kaposi Sarcoma Market

  • 12.1. Latin America Kaposi Sarcoma Market, by Type of Treatment, (US$), 2014-2024
    • 12.1.1. Chemotherapy
    • 12.1.2. Immunotherapy
    • 12.1.3. HAART
  • 12.2. Latin America Kaposi Sarcoma Market, by Distribution Channel, (US$), 2014-2024
    • 12.2.1. Hospitals
    • 12.2.2. Cancer Research Institutes
    • 12.2.3. Multispecialty Clinics
    • 12.2.4. Ambulatory Surgical Centers
  • 12.3. Latin America Kaposi Sarcoma Market, by Country, (US$), 2014-2024
    • 12.3.1. Brazil
    • 12.3.2. Mexico
    • 12.3.3. Rest of Latin America
  • 12.4. Market Attractiveness, by Type of Treatment, 2015
  • 12.5. Market Attractiveness, by Country, 2015

13. Middle East and Africa Kaposi Sarcoma Market

  • 13.1. Middle East and Africa Kaposi Sarcoma Market, by Type of Treatment, (US$), 2014-2024
    • 13.1.1. Chemotherapy
    • 13.1.2. Immunotherapy
    • 13.1.3. HAART
  • 13.2. Middle East and Africa Kaposi Sarcoma Market, by Distribution Channel, (US$), 2014-2024
    • 13.2.1. Hospitals
    • 13.2.2. Cancer Research Institutes
    • 13.2.3. Multispecialty Clinics
    • 13.2.4. Ambulatory Surgical Centers
  • 13.3. Middle East and Africa Kaposi Sarcoma Market, by Country, (US$), 2014-2024
    • 13.3.1. U.A.E.
    • 13.3.2. South African Republic
    • 13.3.3. Rest of Middle East and Africa
  • 13.4. Market Attractiveness, by Type of Treatment, 2015
  • 13.5. Market Attractiveness, by Country, 2015

14. Global Kaposi Sarcoma Market Analysis, By Services

  • 14.1. Radiation Therapy
  • 14.2. Surgery

15. Competitive Landscape

  • 15.1. Growth-Share Matrix of Companies, 2015
  • 15.2. Market Share Analysis, 2015
  • 15.3. Company Profiles
    • 15.3.1. Bristol-Myers Squibb Company
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Business Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Recent Developments
    • 15.3.2. Eli Lilly and Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Business Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Recent Developments
    • 15.3.3. F. Hoffmann-La Roche Ltd.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Business Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Recent Developments
    • 15.3.4. GlaxoSmithKline plc
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Business Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Recent Developments
    • 15.3.5. Johnson & Johnson
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Business Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Recent Developments
    • 15.3.6. Merck & Co., Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Business Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Recent Developments
    • 15.3.7. Pfizer, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Business Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Recent Developments

16. Recommendations

List of Figures

  • Figure 1: Market Segmentation
  • Figure 2: Global Kaposi Sarcoma Market Revenue by Type of Treatment, (US$ Mn), 2014-2024
  • Figure 3: Global Kaposi Sarcoma Market Revenue, by Distribution Channel, (US$ Mn), 2014-2024
  • Figure 4: Global Kaposi Sarcoma Market Revenue, by Geography, (US$ Mn), 2014-2024
  • Figure 5: Value Chain Analysis
  • Figure 6: Global Liposomal Anthracyclines Market for Kaposi Sarcoma, (US$ Mn), 2014-2024
  • Figure 7: Global Alkaloids Market, (US$ Mn), 2014-2024
  • Figure 8: Global Kaposi Sarcoma Market Attractiveness, by Treatment, 2015
  • Figure 9: Global Kaposi Sarcoma Market Attractiveness, by Distribution Channel, 2015
  • Figure 10: Global Kaposi Sarcoma Market Attractiveness, by Region, 2015
  • Figure 11: North America Kaposi Sarcoma Market Attractiveness, by Type of Treatment, 2015
  • Figure 12: North America Kaposi Sarcoma Market Attractiveness, by Country, 2015
  • Figure 13: Europe Kaposi Sarcoma Market Attractiveness, by Treatment, 2015
  • Figure 14: Europe Kaposi Sarcoma Market Attractiveness, by Country, 2015
  • Figure 15: Asia Pacific Kaposi Sarcoma Market Attractiveness, by Type of Treatment, 2015
  • Figure 16: Asia Pacific Kaposi Sarcoma Market Attractiveness, by Country, 2015
  • Figure 17: Latin America Kaposi Sarcoma Market Attractiveness, by Type of Treatment, 2015
  • Figure 18: Latin America Kaposi Sarcoma Market Attractiveness, by Country, 2015
  • Figure 19: Middle East and Africa Kaposi Sarcoma Market Attractiveness, by Treatment, 2015
  • Figure 20: Middle East and Africa Kaposi Sarcoma Market Attractiveness, by Country, 2015
  • Figure 21: Growth Share Matrix, By Key Players (2015)
  • Figure 22: Market Share Analysis by Key Companies (Value %), 2015
  • Figure 23: Bristol-Myers Squibb Company Financial Overview (US$ Mn), 2013-2015
  • Figure 24: Bristol-Myers Squibb Company Revenues by Segment, 2015 (%)
  • Figure 25: Eli Lilly and Company Financial Overview (US$ Mn), 2013-2015
  • Figure 26: Eli Lilly and Company Human Pharmaceutical Products sub-segment revenues 2015 (%)
  • Figure 27: F. Hoffmann-La Roche Ltd. Financial Overview (US$ Mn), 2013-2015
  • Figure 28: F. Hoffmann-La Roche Ltd. Pharmaceutical sub-segment revenues 2015 (%)
  • Figure 29: GlaxoSmithKline plc Financial Overview (US$ Mn), 2013-2015
  • Figure 30: Johnson & Johnson Financial Overview (US$ Mn), 2013-2015
  • Figure 31: Johnson & Johnson Pharmaceutical sub-segment revenues, 2015 (%)
  • Figure 32: Merck & Co., Inc. Financial Overview (US$ Mn), 2013-2015
  • Figure 33: Merck & Co., Inc. Pharmaceutical sub-segment revenues, 2015 (%)
  • Figure 34: Pfizer, Inc. Financial Overview (US$ Mn), 2013-2015
  • Figure 35: Pfizer, Inc. Global Vaccines, Oncology, and Consumer Healthcare sub-segment Revenues 2015 (%)

List of Tables

  • Table 1: Global Kaposi Sarcoma Market, By Type of Treatment Snapshot (2014 - 2024)
  • Table 2: Global Kaposi Sarcoma Market, By Distribution Channel, Snapshot (2014 - 2024)
  • Table 3: Global Kaposi Sarcoma Market, By Geography Snapshot (2014 - 2024)
  • Table 4: Global Kaposi Sarcoma Market, by Type of Treatment, (US$ Mn), 2014-2024
  • Table 5: Global Kaposi Sarcoma Market, by Distribution Channel, (US$ Mn), 2014-2024
  • Table 6: Global Kaposi Sarcoma Market, by Region, (US$ Mn), 2014-2024
  • Table 7: Pipeline Analysis
  • Table 8: North America Kaposi Sarcoma Market, by Type of Treatment, (US$), 2014-2024
  • Table 9: North America Kaposi Sarcoma Market, by Distribution Channel, (US$), 2014- 2024
  • Table 10: North America Kaposi Sarcoma Market, by Country, (US$), 2014-2024
  • Table 11: Europe Kaposi Sarcoma Market, by Type of Treatment, (US$), 2014-2024
  • Table 12: Europe Kaposi Sarcoma Market, by Distribution Channel, (US$), 2014-2024
  • Table 13: Europe Kaposi Sarcoma Market, by Country, (US$), 2014-2024
  • Table 14: Asia Pacific Kaposi Sarcoma Market, by Type of Treatment, (US$), 2014-2024
  • Table 15: Asia Pacific Kaposi Sarcoma Market, by Distribution Channel, (US$), 2014-2024
  • Table 16: Asia Pacific Kaposi Sarcoma Market, by Country, (US$), 2014-2024
  • Table 17: Latin America Kaposi Sarcoma Market, by Type of Treatment (US$), 2014-2024
  • Table 18: Latin America Kaposi Sarcoma Market, by Distribution Channel (US$), 2014-2024
  • Table 19: Latin America Kaposi Sarcoma Market, by Country (US$), 2014-2024
  • Table 20: Middle East & Africa Kaposi Sarcoma Market, by Type of Treatment, (US$), 2014-2024
  • Table 21: Middle East & Africa Kaposi Sarcoma Market, by Distribution Channel, (US$), 2014-2024
  • Table 22: Middle East & Africa Kaposi Sarcoma Market, by Country, (US$), 2014-2024
  • Table 23: Radiotherapy and Surgery (Average cost and Number of procedures)
Back to Top